シンガポール - 英語 - HSA (Health Sciences Authority)

organon singapore pte. ltd. - losartan potassium - tablet, film coated - 100 mg - losartan potassium 100 mg

シンガポール - 英語 - HSA (Health Sciences Authority)

organon singapore pte. ltd. - hydrochlorothiazide; losartan potassium - tablet, film coated - 25 mg - hydrochlorothiazide 25 mg; losartan potassium 100 mg

シンガポール - 英語 - HSA (Health Sciences Authority)

organon singapore pte. ltd. - montelukast sodium 10.4 mg eqv montelukast (core tablet) - tablet - 10 mg - montelukast sodium 10.4 mg eqv montelukast (core tablet) 10 mg

シンガポール - 英語 - HSA (Health Sciences Authority)

organon singapore pte. ltd. - hydrochlorothiazide; losartan potassium - tablet, film coated - 12.5 mg - hydrochlorothiazide 12.5 mg; losartan potassium 50 mg

シンガポール - 英語 - HSA (Health Sciences Authority)

organon singapore pte. ltd. - losartan potassium - tablet, film coated - 50 mg - losartan potassium 50 mg

シンガポール - 英語 - HSA (Health Sciences Authority)

organon singapore pte. ltd. - mometasone furoate - cream - 0.10% - mometasone furoate 1 mg/g

シンガポール - 英語 - HSA (Health Sciences Authority)

organon singapore pte. ltd. - mometasone furoate anhydrous - ointment - 0.10% - mometasone furoate anhydrous 0.1%

シンガポール - 英語 - HSA (Health Sciences Authority)

organon singapore pte. ltd. - betamethasone dipropionate eqv betamethasone - ointment - 0.5 mg/g - betamethasone dipropionate eqv betamethasone 0.5 mg/g

シンガポール - 英語 - HSA (Health Sciences Authority)

organon singapore pte. ltd. - simvastatin - tablet, film coated - 10.0 mg - simvastatin 10.0 mg

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

organon usa inc. - mirtazapine (unii: a051q2099q) (mirtazapine - unii:a051q2099q) - mirtazapine 15 mg - remeronsoltab (mirtazapine) orally disintegrating tablets are indicated for the treatment of major depressive disorder. the efficacy of remeron (mirtazapine) tablets in the treatment of major depressive disorder was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the diagnostic and statistical manual of mental disorders – 3rd edition (dsm-iii) category of major depressive disorder (see clinical pharmacology). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least 5 of the following 9 symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt, or suicidal ideation. the ef